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As the number of membrane proteins in the Protein Data Bank increases, efforts to understand how they interact with their natural
environment are increasing in importance. A number of membrane proteins crystallise with lipid molecules implicitly bound at discrete
locations that are consistent with the transmembrane regions of the protein. Bioinformatics studies also point to the specific interactions
of some amino acids with membrane lipids. The results of experiments using model systems are revealing how these interactions
contribute to the stability of both the protein and the membrane in which it is embedded. From a different perspective, the processes
involved in the binding of peptides to membrane surfaces to produce a variety of effects are being understood in ever-increasing detail.
This review describes current research efforts and thinking in this area.
Introduction
It is now some 42 years since the first structure was proposed for
the biological membrane by Singer and Nicolson1 (Figure 1).
Their fluid-mosaic model comprised a tail-to-tail arrangment of
amphipathic lipid molecules, forming a lipid bilayer. The ‘tails’
of the lipid molecules, the hydrophobic fatty acyl chains,
associated together in the interior of the bilayer in a favourable
like-with-like arrangement that kept them segregated from the
hydrophilic aqueous medium on either side of the membrane.
The ‘heads’ of the lipid molecules, hydrophilic groups such as
choline, were presented on the outside of the membrane in
favourable disposition for solvation by water. Proteins were
present in this model as integral (membrane-spanning) structures
floating in a sea of lipid, or peripheral (extrinsic), bound to the
membrane surface. The model also contained proteins that
traversed one of the membrane lamellae, ie half of the diameter
of the membrane, although proteins of this type may be
relatively rare, as it inevitably implies that hydrophilic groups,
most notably amide bonds in the region of β-turns and random
coil motifs, will be exposed in the region of the hydrophobic
interior of the membrane and therefore poorly solvated. Work in
recent years has demonstrated that natural membranes are much
more complex than this simple model, both in terms of the lipid
distributions found, and the interactions of lipids with other
molecules such as proteins. This review is concerned with the
chemistry of protein-lipid interactions; in particular, the factors
that contribute to the stability of the membrane and the activity
of those peptides and proteins that function in the membrane
environment.
Membrane proteins
When Singer and Nicolson first proposed their model, little was
known about the precise structures of membrane proteins beyond
the fact that many were helical. It was not until Henderson and
Unwin’s model of bacteriophodopsin was published in 1975,5
Fig. 1 The Singer/Nicolson fluid mosaic model. Peripheral proteins are
indicated in green and integral proteins in red.
Fig. 2 Examples of membrane protein structures in the PDB. Key: α-helices are shown in red, β-sheets in yellow; CDL, cardiolipin; PC,
phosphocholine. A, Photosynthetic reaction centre from R. sphaeroides (1m3x);2 B, Cytochrome C oxidase from R. sphaeroides (1m56).3 All lipids in
this model are PE; C, Yeast cytochrome bc1 complex (1kb9).
4 For more details on the lipids bound to this protein, see Figure 3.§
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following years of analytical work by protein chemistry, that the
transmembrane α-helix was described. It is still the case that
membrane proteins are massively under-represented in the
protein databank (PDB),6 but nevertheless the number for which
atomic coordinates are available is increasing steadily. Two
fundamental types of membrane protein may be described:
peripheral and integral.
Peripheral membrane proteins will frequently crystallise in the
absence of lipids, but usually reveal little about the nature of
their contacts with the membrane surface, which may involve
direct contact with the lipids themselves, or with other cell
surface-bound groups such as carbohydrates or integral
membrane proteins. The most well studied surface binding
proteins are phospholipases, including phospholipase A2 C2
domain, which binds to zwitterionic lipids,7 and phospholipase
C, which binds specifically to membrane surfaces that contain
phosphatidylinositol-4,5-bisphosphate through an N-terminal
pleckstrin homology domain.8 A number of proteins involved in
the formation and recycling of vesicular structures, such as those
involved in neurotransmitter signalling, have been recognised
and display interesting activities that are dependent on
membrane curvature (see below). G proteins have also received
much attention as examples of proteins that bind transiently to
membrane surfaces in order to reach their active sites on G
protein receptors.9
A further type of peripheral protein needs to be recognised. A
large number of antimicrobial peptides from a range of
prokaryotic and eukaryotic sources have been isolated, and a
significant number of these exert their activity through
modification of membrane properties. The mechanisms by which
these peptides bind to the membrane surface and subsequently
form membrane lytic structures have been the subject of intense
scrutiny, and will be discussed later in this review.
Integral membrane proteins currently number about 150 in the
PDB. As methods for the preparation of crystals of these proteins
improve, the number is likely to increase more rapidly.11 Of
these, a large number crystallise associated with lipid molecules
(Figure 2). There are currently around 70 entries in the PDB that
contain one or more bound lipids, including examples of, in
decreasing order of occurrence, cardiolipin (CDL),
p h o s p h a t i d y l e t h a n o l a m i n e  ( P E ) ,  s p h i n g o s i n e ,
phosphatidylcholine (PC), phosphatidylglycerol (PG) and
phosphatidylserine (PS). This not only reflects improved
methods for their crystallisation using detergent depletion
methods, which are sufficiently mild to allow lipid molecules to
remain bound to the protein, but also the fact that membrane
proteins do have specific interactions with lipids in the
membrane around them.2,4 There are some striking examples in
the PDB of multiple entries for a single protein that has been
crystallised in different laboratories. A cursory glance at these
reveals that some lipids are invariably bound at the same site on
the protein, regardless of its origin, whereas other lipids are more
variant (Figure 3). Bioinformatics approaches take the evidence
for specific sites of interaction between membrane proteins and
lipids a step further. By examining the distributions of amino
acids across membrane-spanning segments of proteins, it has
been noted that some display a non-random distribution, with a
significant tendency to occur in regions of the protein that
correspond to specific locations with respect to the bilayer. In
one study,12 it was observed that in transmembrane α-helices,
isoleucine was located preferentially in the hydrophobic region
of the extracellular lamella, phenylalanine and tyrosine were
located preferentially in the region of the lipid headgroups of the
intracellular lamella, tryptophan was located preferentially in the
region of the headgroups of both lamellae, and arginine and
lysine were located preferentially in the cytoplasmic residues
flanking the intracellular end of the helix. In a more extensive
study, significant differences were observed between the
distributions of amino acids in α-helical and β-barrel membrane
proteins, although a tendency for aromatic amino acids to occur
in the region of the membrane interface was noted.13
These bioinformatics approaches highlight one of the essential
problems with the study of peptide-lipid interactions: systematic
structural biology approaches are rendered difficult by the
chemical nature of lipids, and the fluid nature of the membrane
environment. Protein-lipid interactions in vivo are intrinsically
dynamic, as lipid molecules are free to move and redistribute
within the bilayer in response to changes in its chemical
composition. For this reason, combined studies using model lipid
systems and molecular modelling approaches provide the best
methods for understanding the fundamental properties of these
interactions, as well as determining their biological significance.
From the above discussion, it will be apparent that that there are
two types of interaction of proteins with membranes that need to
be considered: binding to the membrane surface, involving a
large area of contact between the two, and the interactions of
integral proteins with the lipids that surround them. Both of these
require a firm understanding of the chemical nature of the lipid
bilayer.
Membrane Properties
Fig. 3 A more detailed examination of the lipids bound to yeast
cytochrome bc1 complex (Figure 1C, rotated by 90 °) from alternative
structures in the PDB: A, PDB entry 1kb9; 4 B, PDB entry 1p84.10 Key:
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI,
phosphatidylinositol; CDL, cardiolipin; PA, phosphatidic acid
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The Singer model, although simple, is still a useful starting point
for understanding the structure of membranes. It is beyond the
scope of this review to cover extensively the chemical nature of
lipids, as this is described in many textbooks, however, it will be
necessary to describe the nature of the bilayer in more detail.‡
The liquid crystalline properties of membranes
The lipid bilayer exhibits lyotropic liquid crystalline properties.14
Simple lipids with saturated acyl chains, such as 1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC, Figure 4), exhibit clear
transitions between gel (Lβ’), rippled gel (Pβ’) and liquid
crystalline (Lα) phases in water when the lipid sample is pure.
These transitions are most easily revealed by calorimetry; the
Lβ’-Pβ’ change is generally termed the pre-transition (Tp), and the
Pβ’-Lα change the main transition (T m). Both of these phase
changes are reversible and occur at characteristic temperatures,
with enthalpies of the order of 3 kJ mol-1 for the pre-transition,
and 25 kJ mol-1 for the main transition in DMPC (Figure 5).
Langmuir-Blodgett studies reveal that lipid-lipid interactions in
these membranes are dominated in the Lβ’ phase by close contact
of lipid headgroups, with the acyl chains tilting to maximise Van
der Waals contact.
For unsaturated lipids, with one or more double bonds in one or
both of the acyl chains, such as 1,2-dioleoyl-sn-glycero-3-
phosphocholine (DOPC, Figure 4), phase transition temperatures
are generally much lower in enthalpy, and frequently occur
below 0 °C.14 Membranes composed of these lipids tend to be
much more fluid and expanded than their saturated counterparts,
with lipid-lipid interactions in the Lα phase dominated by close
contact of lipid acyl chains. The effects of other non-lipid
constituents, such as cholesterol in eukaryotic membranes for
example, are described later.
The thermal properties of phase transitions within membranes
are extremely useful indicators of membrane structure, as they
are sensitive both to binding of solutes to the lipid headgroups,
and to partitioning of solutes further into the membrane interior.
The disruptions of lipid packing promoted by peptides and
proteins typically produce changes in T m of ~3 °C for
peptide:lipid ratios of 1:10, with a concurrent decrease in the
enthalpy of the transition and loss of the pre-transition.15
Additional transitions may also be observed in these cases,
which may reflect phase separation effects. Transition
temperatures are also useful indicators of the degree of mixing of
mixtures of lipids. Lipids that mix ideally will have a main
transition temperature that is a statistical average of the values
for the pure lipids, whereas those that do not mix will show
independent transitions for the lipids. This is becoming an
increasingly important issue, as the cases described above for
DMPC and DOPC are rather simple when compared with
biological membranes in vivo. Biological membranes are
complex mixtures of lipids, proteins and carbohydrates, and it is
becoming increasingly clear that they are far from ideal fluid
structures.
The nature of the membrane interface. The surface of the
membrane is a complex environment of intermediate polarity.
Ordered (bound) water in the headgroup region influences a
number of bilayer properties, including diameter, fluidity and Tm
temperature. Extensive studies have been performed with lipids,
covering a large range of hydration states, in order to determine
the number of water molecules that are closely associated with
them. FTIR and dipole potential measurements made on
DMPC/water and DMPC/water/carbohydrate mixtures in
chloroform indicate that of a total of 18 water molecules in the
coordination sphere, 7 are tightly bound, 4 are loosely bound,
with the remaining 7 of intermediate binding.16 Other studies
have found that the free energy of binding water molecules is
zero above molar water:lipid ratios of about 5.17 The inner
sphere waters are likely to be tightly bound to the headgroup and
the carbonyl oxygens and therefore the most difficult to displace.
Nevertheless, bound water can be displaced by solutes, most
strikingly demonstrated by the use of polyhydric alcohols and
carbohydrates as cryoprotectants in liposome preparations.18 In
addition to interfacial water, some experiments provide evidence
that a small amount of water localises in the hydrocarbon region
of the membrane in the Lα state.
19
Metal ions are associated with the membrane surface; divalent
cations have been known to bind especially favourably to
membranes for some time,20 but recent studies suggest that
monovalent cations also associate with membranes.21 These ions
may be modelled as an electrical double layer (Helmholtz
model) and a diffuse layer (Gouy-Chapman model), although
penetration of ions into the hydrocarbon interior of the
membrane under the influence of an electrochemical potential
gradient violates the latter model.22 This does however serve to
remind us of an often neglected aspect of biological membranes
– the membrane potential. Most eukaryotic and many
prokaryotic cells have an electrical potential gradient across the
cell membrane, typically of the order of –90 to -110 mV in the
case of eukaryotes, giving rise to a substantial electric field (~107
V m-1) that has been implicated in the functioning of some
proteins. For example, rotation of a transmembrane helix has
been suggested as a mechanism for the gating of voltage-
sensitive channels.23 However, given that the α -helix has a
modestly strong dipole moment resulting from the alignment of
backbone amides, the role of membrane potential in influencing
the structure and activity of membrane proteins may be worth
more rigorous examination.
Lipid rafts
Fig. 5 DSC enthalpogram for DMPC showing phase changes between
the gel (Lβ’), rippled-gel (Pβ’) and liquid crystalline (Lα) phases. The
Temperatures of the pre- and main transitions are labelled Tp and Tm
respectively.
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Most natural membranes are rather complex mixtures of lipids
that display a level of microinhomogeneity when examined by
microscopic, calorimetric and spectroscopic methods. This may
be attributed to the formation of phase-separated domains, with
condensed phase lipids termed ‘rafts’ coexisting with lipids in
more fluid phases.24 Rafts may be isolated as a result of their
insolubility in non-ionic detergents, and as a result their
molecular content has been the subject of intense scrutiny and
debate.25 Certain lipids, most notably those with high T m
temperatures such as glycosphingolipids (Tm > 40 °C), are in the
gel phase in physiological conditions, and are consequently
major constituents of rafts. Cholesterol also contributes to raft
formation as a result of its favourable interactions with
glycosphingolipids. When added to pure DMPC bilayers,
cholesterol intercalates between the lipid molecules to form a
mixed phase that is intermediate in nature between the gel and
fluid liquid crystalline phases – a so-called liquid-ordered state.26
In natural membranes, cholesterol has a high affinity for gel-
phase glycosphingolipids, leading to the formation of rafts with a
liquid-ordered state. The likely physiological consequence of
cholesterol incorporation is a reduction in bilayer defects in the
interface between the rafts and liquid crystalline phase lipids,
thus increasing membrane stability.
Proteins are the other major constituent of a subset of rafts,
termed caveolae. These rafts have a distinctive invaginated
morphology that is produced by the binding of the protein
caveolin-1 to cholesterol on the cytoplasmic surface of the
membrane.24,27 Interestingly, a number of cell signalling
receptors are found to be localised in caveolae, including
receptor tyrosine kinases, G protein receptors and proteins with
glycosylphosphatidylinositol anchors,24 fundamental ly
challenging the notion that protein receptors are distributed
evenly over the membrane surface. Recent studies have also
shown that the specific activity of phosphatidylinositol transfer
proteins increases in the presence of cholesterol-rich liquid-
ordered domains,28 and the pore-forming peptide equinatoxin II
interacts preferentially with membranes containing
sphingomyelin.29 Caveolae have also been implicated as the
point of entry of pathogenic bacteria such as Chlamydia into
cells.30 As the significance of lipid rafts increases, it should be
anticipated that the reasons why certain proteins are able to
interact selectively with them will be examined in greater detail.
The lamellar distribution of lipids
In addition to the lateral inhomogeneities described above, most
natural membranes are asymmetric from the point of view of the
lipid composition of the lamellae. For example, in the plasma
membrane of eukaryotes, PI, PE and PS have a higher
prevalence in the inner (cytoplasmic) leaflet, whereas PC and
sphingomyelin have a higher prevalence in the outer leaflet.31
Some of these distributions may have clinical significance. For
example, the early stages of apoptosis are marked by the
presence of PS on the external surface of the cell, which renders
the cell more amenable to a number of physiological events,
such as coagulation and recognition by phagocytic cells.31
A number of proteins are involved in the transport of lipids
across the cell membrane,32 including some that are active
(flippases, floppases and aminophospholipid translocase) and
some that are passive (scramblases). Scramblases are non-
specific, and act to equilibrate lipid distribution across a bilayer.
Flippases and floppases are non-specific and require ATP for
their activity, transporting lipids in an inward and outward
direction respectively. Aminophospholipid translocases require
ATP for the transfer of PS and PE molecules in an inward
direction.
There is a great deal of scope for research concerning the
mechanisms by which these proteins function, particularly as
their activity may be of clinical significance. Furthermore, it
should be apparent that synthetic molecules designed to bind
specifically to membrane-bound lipids should be able to
dramatically influence the rate of lipid transfer across the
membrane.
Membrane curvature
Molecular volume and shape are crucial factors in determining
the properties of amphipathic molecules.33 The PCs described
above (DMPC and DOPC) are common constituents of
eukaryotic membranes and may be thought of as having a
rectangular cross-section. When molecules of this shape are
packed into a mesophase, they prefer to form structures of low
intrinsic curvature, ie closed spherical structures of large radius.
Molecules with large polar headgroups preferentially form
structures with high positive intrinsic curvature, ie micelles, and
those with small polar headgroups will form reverse micelles of
negative intrinsic curvature (Figure 6). In fact, most molecules
with lipidic properties will form lyotropic phases other than the
Lα phase described above (such as micellar, inverse-micellar,
hexagonal or cubic) under exceptional conditions. Lipids such as
PE however, form non-bilayer hexagonal (HII) and cubic (QII)
phases much more readily, due to an inherent preference for the
formation of structures of negative curvature.34 This has
important implications for a number of membrane processes in
vivo that require localised areas of negative membrane curvature,
such as membrane fusion (eg during exocytosis) and budding (eg
during endocytosis).35 A number of proteins have been
characterised that are involved in membrane fusion processes,
including viral fusion proteins such as influenza
haemagglutinin,36 and complex protein assemblies such as those
formed by soluble NSF attachment protein receptors (SNARE)
proteins,37 which are involved in trafficking of synaptic vesicles.
Mutagenesis studies on the above proteins have allowed
intermediates in the fusion process to be isolated, and these
hemifusion products confirm their role in the fusion process.
Perhaps the best example of the effects of membrane curvature
on protein activity is provided by the amphiphysins. These
proteins are involved in the recycling of neurotransmitter
vesicles, and feature a conserved domain, termed the BAR
domain, which is found in a number of similar proteins of
eukaryotic origin. These include Arf-GTP, which is involved in
the formation of clathrin-coated vesicles,38 and centaurins, which
are involved in vesicular trafficking. The BAR domain is a
homodimer, produced by a head-to-head arrangement of two
kinked coiled-coil motifs (Figure 7), and binds to membranes in
Fig. 6 The formation of aggregates of different specific curvature
according to amphiphile shape.
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a fashion that is remarkably sensitive to membrane curvature,
producing effects that are visible both in cell preparations and
synthetic liposomes.39
Highly curved membrane structures are also implicated in a
number of the pore formation mechanisms of antimicrobial
peptides that are discussed later. In all of these cases, protein-
membrane binding promotes the formation of energetically
unfavourable structures characterised by a high degree of
curvature strain. The factors that produce tight protein-lipid
binding, and the design of new molecules to alter membrane
curvature in a controllable manner are likely to be highly active
research areas in the future.
Peptide-Lipid Interactions
Methods for studying peptide-lipid interactions
In recent years, there have been some tremendous improvements
in the methods available for studying the interactions of peptides
with membranes. It is beyond the scope of this review to cover
these in detail, but an awareness of the nature and potential
benefits of these methods should facilitate the design of new
experiments.
Calorimetry has been used for some time for the analysis of lipid
phase changes. Recently however, significant improvements in
the instrumentation available have enabled far more sensitive
measurements to be made, giving access to the full
thermodynamic parameters (ΔG, ΔH and Δ S) for a given
system.40 Isothermal titration calorimetry (ITC) allows binding
isotherms to be measured, which should enable more difficult
problems of relevance to peptide-lipid interactions to be
addressed, such as the role of interfacial water in binding. Water
sorption calorimetry has proved useful in measuring the energy
associated with water binding to membranes, and should also
prove useful for determining the fate of water during peptide
binding.
Scanning probe microscopies have matured considerably and
offer an excellent method for visualising the structures that are
formed by peptides and proteins in membranes.41 A particular
advantage with these approaches is the ability to perform the
experiments directly on aqueous membrane preparations. This
enables the visualisation of 2D arrays of membrane proteins,
(which are easier to form than 3D crystals), and the types of lipid
phases that are formed by peptide-lipid mixtures.  Atomic force
microscopy (AFM) can provide resolutions as high as 5 Å, and
has allowed the direct visualisation of the pores formed by a
number of channel proteins such as OmpF42 and α-Hemolysin in
membranes. In the latter case, the 2D crystals formed with the
protein assembled as a homohexamer,43 contrasting with the
structure obtained by conventional crystallographic methods, in
which the protein assembled as a homoheptamer.44 This
demonstrates one advantage of studying membrane proteins in
their natural environment. AFM also allows the measurement of
forces between single biomolecules, potentially allowing a direct
measurement of peptide-lipid interactions.45 This may provide
useful information on the various interactions that drive stable
protein assembly in the membrane.
Methods for quantifying peptide-lipid binding, including surface
plasmon resonance46 and the quartz crystal microbalance,47 now
enable the association constants of peptides with supported
membranes to be measured extremely accurately. Together with
single molecule force measurements by AFM, it should be
possible to use these methodologies to systematically probe the
energetic characteristics of peptide-lipid interactions as a
function of the chemical structure of the lipid and the peptide, in
order to understand the relative importance of the non-covalent
interactions that are involved.
In order to probe the structure of peptide-lipid adducts, a number
of spectroscopic techniques have found application, including
NMR,48 linear and circular dichroism,49 and attenuated total
reflection FTIR.50 All of these methods may be performed on
oriented bilayers, providing information on the orientation of
peptides with respect to the bilayer normal,51 as well as
information concerning the 2° structure of the peptide. NMR
spectroscopy has proved particularly useful where information is
already available for the structure of a peptide in the absence of
membranes, as coupling constants and chemical shift
anisotropies may be monitored to assess changes in
conformation following binding.52 Raman spectroscopy has also
been applied to liposomes,53 and should prove useful for the
study of peptide-lipid interactions in the future.
Helical peptide models for integral membrane proteins
Properties such as bilayer thickness are able to influence the
activity of proteins. For example, when reconstituted into
synthetic membranes of differing thickness, Ca2+-ATPase and
(Na+,K+)-ATPase display maximum activity when the lipid acyl
chains are 18C in length.54 The effects of peptide-lipid
interactions, both on the properties of bilayers and the activity of
membrane proteins, have therefore received much scrutiny.
Hydrophobic mismatch,55 in which the length of the
hydrophobic region of the peptide is different to the diameter of
the hydrophobic interior of the membrane, has been examined
intensively using helical peptides.56 These studies address some
of the fundamental issues around the effects of membrane lipids
on protein structure and vice versa. In response to hydrophobic
mismatch, a number of effects are imaginable, which may be
broadly considered as changes in the structure of the peptide or
modification of bilayer properties (Figure 8). These effects are
dependent on the nature of the mismatch, i e whether the
hydrophobic part of the peptide is shorter or longer than that of
the bilayer, and the composition of the membrane. Regardless of
the changes that occur, the net effect is to reduce the extent of
exposed hydrophobic residues.
Aggregation of peptides in response to changes in lipid diameter
has been demonstrated for model transmembrane helical
peptides, of sequence Ac-KKGLmXLnKKA-NH2, where X is
3,5-dibromotyrosine or tryptophan, and 12 and 10 are typical
values for m  and n respectively.57 Following incorporation of
mixtures of these peptides into synthetic membranes, quenching
of tryptophan fluorescence by 3,5-dibromotyrosine was used to
quantify their dimerisation. Association constants for
dimerisation increased markedly as the length of the lipid chains
was increased, with the free energy of dimerisation increasing by
0.5 kJ mol-1 per acyl chain carbon. Furthermore, association
constants were phase-dependent, being much higher in the
liquid-ordered phase of a cholesterol:DOPC mixture than the Lα
phase of pure DOPC. However, this increase in binding was
much more than would be expected as a result of the change in
bilayer diameter produced by the inclusion of cholesterol alone,
and may therefore reflect the higher packing density in liquid-
ordered phases. A change in helix tilt with respect to the
membrane was a further consideration in these experiments, as a
packing angle of 20° between helices is optimal for inter-helix
interactions.58 In this regard, studies on model peptides of
sequence KK(A)m(LA)nKK, in which m  = 0 or 1 and n  = 5-15,
demonstrated that at low peptide:lipid ratios, hydrophobic
Fig. 7 Spacefilled representation of he assumed biological molecule of
the BAR domain from amphiphysin (PDB entry 1uru).39
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mismatches in which the peptide was 3 Å too short or 14 Å too
long did not alter the peptide orientation with respect to the
membrane,59 similar to other results using lysine as membrane-
anchoring residues.60
Although some studies have been able to detect evidence for
peptide conformational changes in response to lipid phase
changes,61 these effects have generally been very small, and it
seems that most peptides adopt the same conformation
regardless of lipid phase.
Lipid disordering has been demonstrated using a number of
natural and designed peptides. The most striking are the so-
called WALP peptides studied by Killian and co-workers.62
These peptides were designed to incorporate differing lengths of
hydrophobic stretch between anchoring tryptophan or lysine
residues (Table 1).
Interestingly, the shorter peptides such as WALP16 were able to
induce the formation of non-lamellar HII phases, and it was noted
that the inter-tryptophan distance was the crucial factor for
determining the activity of W2
inALP16 and W2
outALP16, rather
than the length of the hydrophobic segment. 2H NMR
experiments also provided evidence that WALP16 produced an
increase in acyl chain order, with concomitant increase in bilayer
diameter of 0.4 Å. Solid-state 1H NMR analysis of WALP
peptide/DMPC mixtures produced upfield chemical shift
changes (relative to pure DMPC) for several of the key lipid
signals, with the magnitude of the chemical shifts increasing
with increasing peptide length. In particular, the changes
observed for the choline group of the lipid were attributed to ring
current effects of tryptophan.  On the basis of this, the authors
propose that the indole ring of tryptophan locates preferentially
in the region of the acyl carbonyl groups, consistent with other
reports.63 Whether there are specific dipolar interactions between
tryptophan residues and lipids in these helical peptides is open to
question, although experiments using tryptophan analogues did
not change the location of the tryptophan with respect to the lipid
bilayer, suggesting that, at least in this case, dipolar interactions
may be small.63
Parallel experiments with the equivalent peptides containing
lysine in place of tryptophan produced different results. For
example the peptide KALP23 produced an increase in bilayer
thickness of 0.2 Å, compared with 1.0 Å observed with
WALP23, and the longer peptide KALP31 only produced an
increase in bilayer diameter of 0.3 Å, pointing to the importance
of the membrane anchoring role played by tryptophan in the
WALP peptides.
Taken together, these results are consistent with the earlier
findings of bioinformatics studies that point to specific roles for
aromatic amino acids, especially tryptophan, at the membrane
interface in the region of the polar headgroups.12,13
Gramicidin A (gA) is a naturally occurring peptide antibiotic of
sequence Formyl-V-G-A-D-L-A-D-V-V-D-V-W-D-L-W-D-L-W-
D-L-W-ethanolamine. It has been one of the most well studied
membrane-active peptides, principally because it has a well
characterised structure and it displays interesting biophysical
properties. In organic solvents, the peptide adopts helical dimer
conformations. In membranes however, as a result of the unusual
alternating sequence of D- and L-amino acids, the peptide adopts
a β6.3 right-handed helical conformation.64 The monomer is
approximately 10.5 Å in length, less than the diameter of a single
lamella in most membranes. gA monomers diffuse laterally in
the membrane, and monomers in different lamellae are able to
form head-to-head (N-terminal-to-N-terminal) dimers (Figure 9).
These dimers function as ion channels that are selective for
cations, and this is the basis for their antibiotic activity.
A number of studies have examined the effects of gA
incorporation on the properties of lipid bilayers. gA insertion
into bilayers is accompanied by dehydration of the lipid
headgroups surrounding the peptide (the so-called boundary
lipids).65 ESR studies66 have shown that these boundary lipids
become more ordered, adopting a more gel-like state than the
surrounding lipids, which remain in the liquid-crystalline phase.
As a result, the boundary lipids become extended in a direction
normal to the plane of the bilayer, increasing the extent of the
hydrophobic mismatch between the peptide and the membrane.
This in turn leads to curvature strain on the membrane that, it has
been suggested, contributes to the formation of HII phases, which
are known to form at high gA:lipid ratios.67 Using small-angle x-
ray techniques, the intrinsic radius of curvature of gA in DOPC
bilayers has been estimated as –7.4 Å.68 Other ESR studies with
DMPC have concluded that the number of boundary lipid
molecules with restricted motion is three to four per gA
monomer.69 The same study found that gA has little effect on the
tilt angle of the lipid acyl chains in either the gel or liquid-
crystalline phase of DMPC, with the gA aligned along the same
axis as the acyl chains in the latter case. In the gel phase
however, the gA monomer exhibited a greater tilt angle than the
lipid chains. With other lipids (PE, PS and PG), gA was less well
oriented. In common with many of the peptides encountered in
Fig. 9 The structure of the gramicidin A helical dimer in DMPC
determined by solid-state NMR methods (from the PDB entries 1mag)64
Fig. 8 Mechanisms by which peptide-lipid systems may adapt to
hydrophobic mismatch. Adapted from reference 55.
Table 1 WALP and KALP peptides studied by Killian and co-workers62
peptide sequence a hydrophobic stretch (Å)
WALP16 Ac-GWW(LA)5WWA-Etn 15.0
W2
inALP16 Ac-GAW(LA)5WAA-Etn 15.0
W2
outALP16 Ac-GW(LA)5LAWA-Etn 18.0
WALP17 Ac-GWW(LA)5LWWA-Etn 16.5
WALP23 Ac-GWW(LA)8LWWA-Etn 25.5
KALP23 Ac-GKK(LA)8LKKA-Etn 25.5
KALP31 Ac-GKK(LA)12LKKA-Etn 37.5
aEtn = ethanolamine
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this review, the termini of the helical dimer in the region closest
to the membrane interface are marked by the presence of
tryptophan residues, which are aligned with the indole-NH
groups facing the extracellular medium and the indole dipole
aligned along the channel axis. These tryptophan residues serve
the twin purposes of aligning the peptide in the bilayer, and
enhancing channel conductance.70
β-Sheet models for integral membrane proteins
A significant number of membrane proteins in the PDB have a
β-barrel structure. These proteins are mostly prokaryotic outer
membrane proteins, isolated from Gram negative bacteria, where
they serve as transmembrane pores for a range of functions, such
as drug efflux, nutrient influx and protein transport. Whilst some
of these are important therapeutic targets, others have potential
biotechnology applications. For example, a number of
autotransporters have been characterised that are able to catalyse
the transfer of parts of their own polypeptide chain across the
membrane through a β-barrel pore.71 Cleavage of the transported
protein fragment releases a soluble protein on the trans side of
the membrane, leaving the pore behind. Peptides that are
designed to mimic these pores may have potential applications as
agents for macromolecule delivery into cells. Finally, a number
of peptide toxins insert into membranes to form β-structures that
are responsible for lytic activity.
An understanding of the factors that promote stable assembly in
the membrane is therefore important. The group of White and
co-workers have developed a peptide model for studying the
formation of β-structures in membranes.72 Their peptide, of
sequence Ac-WL5, exists in solution as a monomer with a
random coil conformation. Following insertion into the
membrane as a random coil, the peptide aggregates and adopts a
β-sheet conformation with the inter-strand hydrogen bonds
aligned parallel to the plane of the membrane, as determined by
CD and IR experiments. Interestingly, peptide insertion is
cooperative and coupled to β -sheet formation. Thermal
denaturing experiments indicate that the midpoint temperature
for unfolding of the aggregate is ~60 °C, and establishes that the
process is an equilibrium, with the β-sheet aggregate in
equilibrium with a membrane inserted random coil monomer,
which is in turn in equilibrium with the random coil monomer in
aqueous solution (Figure 10). Although the formation of β-
structures by this and related peptides73 correlates poorly with
the sheet-forming propensities of the constituent amino acids in
globular proteins, the observation of β-sheets in the bilayer
environment points to the importance of polar interactions, in
this case hydrogen bonds, within this environment. Studies using
coiled-coil proteins have found that polar residues, such as
asparagine, are preferentially located on the sides of α-helices
that are involved in protein-protein contacts when located deep
in the bilayer, but may be found on the lipid exposed surface of
helices near the membrane interface,74 which is also consistent
with the increased importance of polar residues in controlling
protein conformations in the bilayer interior. White estimates
that the free energy gain for the formation of a hydrogen bond in
the membrane environment is of the order of between 0.46 and
0.61 kcal mol-1 per residue when compared with a solvated
peptide bond in water. Even if this value is an overestimate, it
still points to the reason why some membrane proteins have
extremely thermostable structures. It also explains why the Ac-
WL5 peptide forms sheet rather than helix structures in
membranes, as the number of exposed peptide bonds is
minimised in sheets. The adoption of helical conformations
would expose a significant number of peptide bonds at the helix
ends. Consistent with this, a number of longer leucine-containing
peptides that we have already discussed are able to adopt helical
transmembrane conformations, as the proportion of peptide
bonds exposed is much smaller in these peptides.
The effects of hydrophobicity were also addressed by White and
co-workers. Longer, more hydrophobic peptides such as Ac-WL6
were found to have higher partition constants with lipid
membranes and were stable towards thermal degradation.72 This
was attributed in part to the cooperativity of β-sheet formation,
coupled with the considerably more favourable partitioning of
the monomer into the membrane. Shorter peptides, such as Ac-
WL4 had only poor interactions with membranes. A more
systematic study using analogues of the antimicrobial peptide
indolicidin produced a linear relationship between the free
energy of partitioning from water to neutral PC membranes and
peptide hydrophobicity.75 These studies demonstrate that
hydrophobicity alone is an indication of the tendency of peptides
to insert into neutral membranes in some cases.
An important consideration concerning peptide aggregation
within membranes is the role of Van der Waals interactions:
protein-protein interactions compete with protein-lipid and lipid-
lipid interactions. As a consequence, Van der Waals interactions
on their own may not be sufficient to drive aggregation in the
low dielectric close-packed environment of the bilayer. The
association of transmembrane helices for example, requires their
surfaces to have highly complementary shapes, permitting tight
‘knob-into-hole’ packing that favours peptide-peptide
interactions over peptide-lipid interactions.76
Antimicrobial peptides: surface interactions
There is now a considerable body of work on the structural
diversity and mechanism of action of a vast array of peptides
with antimicrobial activities. It is beyond the scope of this
review to describe all of these, and they have been amply
described elsewhere.77 This discussion will be restricted to those
for which peptide-lipid interactions have been characterised.
Pore forming mechanisms. There are currently three proposed
mechanisms by which membrane-lytic peptides function (Figure
11).78 A common feature of all of these is initial binding of the
peptide to the membrane surface, which is mediated by a
combination of hydrophobic and electrostatic effects. Many
antimicrobial peptides are cationic, and bind to the surface of
negatively-charged membranes through electrostatic interactions.
A key factor here in determining peptide selectivity is the
composition of the membrane.‡ Many eukaryotic cell
membranes are composed mainly of neutral (zwitterionic) lipids.
This includes red blood cells, the poration of which is easily
monitored by haemolysis assays, providing a measure of peptide
activity. Prokaryotic cells, on the other hand, tend to contain
more negatively charged lipids, such as PG and CDL. Whilst this
provides a mechanism for the selectivity of cationic peptides, it
is not the whole story. Peptides have also been characterised that
bind selectively to membranes containing cholesterol (which is
not found in prokaryotic membranes), such as streptolysin O and
perfringolysin.
Whilst initial binding to the membrane may be driven by
electrostatic effects, hydrophobic effects are also important. The
Fig. 10 Formation of β-sheet structures by the peptide Ac-WL5. Adapted
from reference 72.
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work to study the effects of hydrophobicity on the membrane
partitioning of model peptides described earlier,75 also found that
electrostatic and hydrophobic effects were not additive, with the
electrostatic effect often being overestimated. One of the reasons
why the relative importance of these effects is difficult to assess
is the change in conformation that many peptides undergo upon
binding to the membrane surface. For example, the magainins
are cationic peptides that adopt an amphipathic α -helical
conformation following surface binding.79 Protegrin-1, a peptide
stabilised by two disulphide bridges, functions in the porcine
immune system as a broad-spectrum antimicrobial agent. Both
the parent peptide and analogues containing more or fewer
disulphide bonds retain their activity, and are predicted to form
amphipathic β -structures when bound to the membrane,
suggesting that interaction with the membrane is sufficient to
induce folding.80 Many other peptides adopt amphipathic
conformations following surface binding, as this places
hydrophilic and hydrophobic residues in favourable dispositions
for solvation or interaction with the lipid interior respectively. In
at least one case, evidence is provided for peptide aggregation
prior to membrane interaction, but it remains to be seen how
general this is.81 Cases have also been described of pH-
dependent changes in the conformation of proteins leading to the
exposure of hydrophobic residues that are then able to drive
membrane insertion.82
A number of studies have addressed the nature of the
interactions between peptides and the surface region of the
bilayer. The human antimicrobial peptide LL-37 is an
amphipathic α-helix that embeds in the bilayer in the region of
the headgroups and aligns parallel to the membrane surface.83 2H
NMR studies indicate that LL-37 produces disordering of gel
phase DMPC bilayers and conversely, ordering of unsaturated
bilayers. Mellitin, a well-studied peptide from bee venom, inserts
at low concentrations into bilayers in a similar fashion to LL-37,
aligning parallel to the membrane surface whilst penetrating to
the depth of the glycerol region of the lipid.84 One novel
approach to determining the orientation of the fusogenic peptide
B18 in membranes has been to use solid-state 19F NMR
measurements on fluorine-labelled B18 analogues.85
Incorporation of L-4-fluorophenylglycine at distinct locations in
the peptide did not perturb the kinked α-helical structure of the
peptide, and the measurement of 19F chemical shift anisotropies
in oriented membranes enabled the respective orientations of the
peptide fragments N- and C-terminal to the kink to be estimated
as 54° and 91° with respect to the bilayer normal, with the N-
terminus of the peptide located at the membrane interface.
All of the mechanisms of membrane poration that follow binding
to the surface occur once the bound peptide:lipid ratio has
reached a critical value (P:L*).
The carpet mechanism (Figure 11) involves peptides binding
parallel to the membrane surface to form clusters that cover the
surface with a ‘carpet’ of peptide. In some cases, the distinction
between surface binding and slight penetration into the bilayer
may be difficult to determine. No generalisations can be made
concerning peptide structure in these carpets, but it is generally
accepted that peptide activity is not detergent-like, occurring
instead by the exertion of disruptive forces on the membrane.
The redistribution of lipids in one of the membrane lamellae in
response to peptide binding is likely to produce significant
curvature strain on the membrane, leading to disruption.
The toroidal mechanism involves initial peptide binding to the
membrane surface to form an α-helix that is aligned in the plane
of the membrane. Studies on magainin, a peptide from the skin
of the African clawed frog,79 demonstrate that, as with LL-37,
slight penetration into the headgroup region of the bilayer
occurs. This disrupts lipid-lipid interactions, leading to
membrane thinning, placing the membrane under positive
curvature strain. At the critical P:L ratio (P:L*), breakdown of
the bilayer occurs and the peptides realign to adopt a
transmembrane orientation. Self-association of the helices leads
to the formation of a protein-lined pore. It should be apparent
that many of the steps resemble those of the carpet mechanism,
and indeed, both require peptides that are able to promote
curvature strain in membranes. It should also be apparent that
peptides that are able to produce curvature strain may potentially
form inverted hexagonal phases if present in sufficient
concentration. This has been demonstrated for the designed
antimicrobial peptide MSI-78.86 One striking example of the
propensity for antimicrobial peptides to produce curvature strain
is provided by the interaction of equinatoxin II with DMPC/SM
membranes.29 Freeze-fracture electron micrographs of mixtures
of the toxin with DMPC/SM liposomes show the presence of
small unilamellar vesicles of diameter 20-40 nm, presumably
reflecting the preference of the protein-lipid mixture to form
highly curved structures.
The barrel-stave mechanism is proposed for a select group of
peptides, the most studied of which is alamethicin. Peptide
monomers assemble on the membrane surface, oriented with
respect to the membrane according to their amphipathicity. Upon
reaching the threshold concentration, monomers aggregate and
insert into the membrane to form a pore lined with a mixture of
peptides and lipid. The pore is a dynamic molecular assembly
that is able to recruit or lose peptides according to local
concentration gradients. As a consequence, the sizes of the pores
formed by these peptides are relatively polydisperse. The
channels formed by alamethicin have a diameter of 2-3 Å,
corresponding to the recruitment of 4-6 monomers. The unusual
sequence of the peptide, which contains α-aminoisobutyric acid
(Aib) and phenylalaninol, points to the mechanism by which the
peptide forms pores. In the crystal structure of the peptide
(Figure 12), the backbone is predominantly helical, with a kink
at residue 14 (proline). The Aib residues enable strong
interhelical packing interactions, whilst the kink increases the
flexibility of the helix, an effect that studies on model peptides
indicate should minimise peptide aggregation in solution.87 A
similar kink is found in the membrane-penetrating peptide
buforin II. Removal of this kink by substitution of leucine for
proline produced a peptide without antimicrobial activity that
bound to the membrane surface.88
Some work has pointed to mellitin forming pores by a barrel-
stave mechanism,90 although other researchers suggest that this
peptide forms pores through a toroidal pathway.91 There is
clearly some room for speculation as to the precise mechanisms
by which these peptides function, and it is entirely feasible that
different mechanisms may be observed in the presence of
alternative lipid mixtures.
Fig. 11 Pore-forming mechanisms of antimicrobial peptides.
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Designer antimicrobial peptides. Some natural peptides, such
as the gramicidins, have been used in topical applications for
some time. In general however, the design of new peptides with
specific activity is not trivial. An understanding of the
mechanisms by which antimicrobial peptides function
selectively on different cell types is essential, which in turn
requires that the detailed molecular basis of peptide-lipid
interactions are understood. The need for this arises because the
diversity of antimicrobial peptides is considerably greater than
the mechanisms by which they function. Peptides that are vastly
different in sequence and structure may share the same
mechanism for pore formation, and this presents a serious
challenge to understanding the basics for designing a new
peptide. The most successful approaches have tended to
commence by modification of peptide of known activity, with
some useful outcomes. For example, modification of platelet
antimicrobial proteins has lead to the production of novel
peptides that are non-haemolytic, and therefore suitable for use
in blood-based media.92
In order to be of more general use, such as for oral applications,
the problem of digestion by proteases needs to be overcome.
Approaches to achieving this have included the preparation of
peptides with reduced amide bonds,93 and the design of peptides
based around β-amino acids, which are not natural substrates for
proteases.94 The groups of Gellman, DeGrado and Seebach have
extensively investigated the structure and lytic activity of a series
of β-peptides. These peptides tend to form helical structures that
are more stable than the α-helix. Peptides 1 and 2, for example,
adopt 14-helical conformations in membranes, with hydrogen
bonds between the C=O of residue i and the NH of residue i-2
forming a 14-membered ring.95
Peptides 1 and 2 have potent antimicrobial activity and low
toxicity to mammalian cells. Furthermore, these peptides have
been shown to induce lipid flip-flop in membranes containing
anionic lipids and promote membrane fusion. The latter activity
was attributed to the induction of negative curvature strain
following the binding of these peptides to membranes at low
concentrations.95 The more conformationally restricted peptide
β -17, designed around analogues of t r a n s - 2 -
aminocyclopentanecarboxylic acid, forms an amphipathic 12-
helix that also displays promising antimicrobial activity and low
haemolytic activity.96
Studies on the binding of this peptide to lipid membranes have
reached similar conclusions to those arrived at for peptides 1 and
2. These peptides therefore share the common property of being
able to induce negative curvature strain, and in this respect are
different from other antimicrobial peptides, such as magainin II,
that act by inducing positive curvature strain.97
Fundamental lipid binding studies
This last section describes some of the current approaches that
are being explored to develop small-molecule systems that
reveal fundamental aspects of the interactions between amino
acids and lipids. From the above discussion it will be apparent
that the membrane interface is a complex environment, and it is
therefore of interest to examine specific details of the
interactions that occur between amino acids and lipids in the
absence of complicating factors.
Work in our group has developed a model system for probing the
preferred interactions between amino acids and lipids in non-
competing solvents. Our system comprises a PC such as diacetyl
PC (3) or DMPC as a host in titrimetric experiments with N-
acetyl amino acid N-ethyl amides (4, 5) as hosts. The system
maintains all of the functionality present in natural systems, and
has allowed us to measure the association constants of each
amino acid with 3 by 1H NMR titration.98 From these studies, we
were able to show that tryptophan and tyrosine binding to PC
headgroups was significantly more favourable than the binding
of either phenylalanine or valine, a finding consistent with the
bioinformatics studies described earlier.12,13 Furthermore, both
tryptophan and tyrosine formed 2:1 complexes with the lipid and
in the case of tryptophan, we were able to observe intermolecular
contacts by 2D ROESY spectroscopy. These were used to
generate distance restraints that could be used to examine the
interactions by molecular modelling (Figure 13). Adduct
formation was characterised by indole-NH---phosphate hydrogen
bonds, indole---choline cation-π interactions, amide C=O---
choline ammonium coordination, and amide-NH---phosphate
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Fig. 12 X-ray crystal structure of Alamethicin (PDB entry 1amt).89
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Fig. 13 Models for the interaction of tryptophan with PC headgroups.
Each model is a representative structure from groups of structures
generated by dynamics calculations.98
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hydrogen bonds. In more recent work, we have found that the
observed association constants are markedly dependent on the
water content of the sample, and titrations with DMPC in place
of 3 (which is highly hygroscopic) produce significantly higher
association constants.99 During the course of this work, we also
observed that water bound to the choline headgroup of DMPC
was displaced, suggesting that this may be a consequence of
tryptophan coordination. Although our results differ from those
reported earlier for the coordination of tryptophan in
transmembrane helices, our system is not restrained by the
requirement of residing in the bilayer, and therefore is probably
of more relevance to the surface-bound conformations described
earlier for antimicrobial peptides. It is interesting to speculate
that dehydration of PC headgroups by tryptophan may be
responsible for some of the curvature strain effects that are seen
with these peptides.
A number of synthetic receptors for PC headgroups have been
designed, which shed some light on the interactions that favour
lipid binding.100 Calixarene 6 has an association constant in
chloroform of 7.3 ± 0.5 x 104 M-1 with DOPE. Complex
formation in this case is enthalpic, and requires both the
guanidinium functionality and the calixarene cavity.101 NMR
studies on the 1:1 complex are consistent with inclusion of the
choline headgroup in the cavity of the calixarene. Synthetic
receptors based on TREN (tris(2-aminoethyl)amine) exhibit
selective binding of PC over PE and PS. These compounds, such
as sulphonamide 7, are able to mimic scramblase activity by
altering the distribution of lipids within the membrane.102 In this
series of compounds, complexation with the phosphate seems to
be the major determinant of binding, as derivatives with
increased amide acidity were better at PC complexation. This
echoes the important role of hydrogen bonding to the phosphate
that we observed in our studies.98
Prospects
We have discussed a number of features of peptide-lipid
interactions in this review. Some general conclusions concerning
these interactions may be drawn: (1) electrostatic and
hydrophobic effects contribute to peptide binding to membrane
surfaces; (2) hydrophobicity is an important controlling factor in
peptide partitioning into membranes. Peptides of low
hydrophobicity tend to reside outside the bilayer, whereas those
that are highly hydrophobic partition into all membranes, and
usually do not discriminate between mammalian and prokaryotic
cells; (3) tryptophan has an important role in membrane
anchoring. Other aromatic amino acids may also have special
roles in peptide binding; (4) most surface-active peptides are
amphipathic, or can adopt an amphipathic conformation
following membrane binding; (5) transmembrane peptides and
proteins need complementary shapes in order to aggregate, due
to the finely balanced nature of the competing peptide-lipid and
lipid-lipid interactions; (6) dipolar (electrostatic) interactions are
more favourable in free energy terms in the hydrophobic part of
the bilayer than in water; (7) peptide binding influences the
phase properties of the membrane and the distribution of
boundary lipids. Lytic and fusogenic peptides mediate their
activity through the curvature strain that results from these
changes; (8) whilst there is some evidence that membrane-bound
peptides are able to displace interfacial water, the role of water
in peptide-lipid interactions is not currently well defined.
Whilst, through a great deal of effort, the factors that contribute
to peptide-lipid interactions are beginning to be understood,
many opportunities remain for the organic chemist to design new
systems that address some of these issues.
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